• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏康复对心力衰竭患者预后的影响:呼吸肌力量的变化

Changes in Respiratory Muscle Strength Following Cardiac Rehabilitation for Prognosis in Patients with Heart Failure.

作者信息

Hamazaki Nobuaki, Kamiya Kentaro, Yamamoto Shohei, Nozaki Kohei, Ichikawa Takafumi, Matsuzawa Ryota, Tanaka Shinya, Nakamura Takeshi, Yamashita Masashi, Maekawa Emi, Meguro Kentaro, Noda Chiharu, Yamaoka-Tojo Minako, Matsunaga Atsuhiko, Ako Junya

机构信息

Department of Rehabilitation, Kitasato University Hospital, Sagamihara 252-0375, Japan.

Department of Rehabilitation, Kitasato University School of Allied Health Sciences, Sagamihara 252-0373, Japan.

出版信息

J Clin Med. 2020 Mar 30;9(4):952. doi: 10.3390/jcm9040952.

DOI:10.3390/jcm9040952
PMID:32235491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7230659/
Abstract

Respiratory muscle weakness, frequently observed in patients with heart failure (HF), is reported as a predictor for poor prognosis. Although increased respiratory muscle strength ameliorates exercise tolerance and quality of life in HF patients, the relationship between changes in respiratory muscle strength and patient prognosis remains unclear. A total of 456 patients with HF who continued a 5-month cardiac rehabilitation (CR) were studied. We measured maximal inspiratory pressure (PI) at hospital discharge as the baseline and five months thereafter to assess the respiratory muscle strength. Changes in PI during the 5-month observation period (⊿PI) were examined. We investigated the composite multiple incidence of all-cause death or unplanned readmission after 5-month CR. The relationship between ⊿PI and the incidence of clinical events was analyzed. Over a median follow-up of 1.8 years, 221 deaths or readmissions occurred, and their rate of incidence was 4.3/100 person-years. The higher ⊿PI was significantly associated with lower incidence of clinical event. In multivariate Poisson regression model after adjustment for clinical confounding factors, ⊿PI remained a significant and independent predictor for all-cause death/readmission (adjusted incident rate ratio for ⊿PI increase of 10 cmHO: 0.77, 95% confidence interval: 0.70-0.86). In conclusion, the changes in respiratory muscle strength independently predict the incidence of clinical events in patients with HF.

摘要

呼吸肌无力在心力衰竭(HF)患者中经常可见,据报道是预后不良的一个预测指标。尽管呼吸肌力量增强可改善HF患者的运动耐量和生活质量,但呼吸肌力量变化与患者预后之间的关系仍不明确。本研究共纳入了456例持续进行5个月心脏康复(CR)的HF患者。我们在出院时测量最大吸气压(PI)作为基线值,并在5个月后再次测量以评估呼吸肌力量。观察5个月期间PI的变化(⊿PI)。我们调查了5个月CR后全因死亡或非计划再入院的综合发生率。分析了⊿PI与临床事件发生率之间的关系。在中位随访1.8年期间,发生了221例死亡或再入院事件,其发生率为4.3/100人年。较高的⊿PI与较低的临床事件发生率显著相关。在调整临床混杂因素后的多变量泊松回归模型中,⊿PI仍然是全因死亡/再入院的一个显著且独立的预测指标(⊿PI每增加10 cmH₂O的调整事件发生率比:0.77,95%置信区间:0.70 - 0.86)。总之,呼吸肌力量的变化可独立预测HF患者临床事件的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/3467637c19e9/jcm-09-00952-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/83aa932c3df7/jcm-09-00952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/34018a28a683/jcm-09-00952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/7df129274fd6/jcm-09-00952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/743caea00dd9/jcm-09-00952-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/3467637c19e9/jcm-09-00952-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/83aa932c3df7/jcm-09-00952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/34018a28a683/jcm-09-00952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/7df129274fd6/jcm-09-00952-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/743caea00dd9/jcm-09-00952-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4395/7230659/3467637c19e9/jcm-09-00952-g005.jpg

相似文献

1
Changes in Respiratory Muscle Strength Following Cardiac Rehabilitation for Prognosis in Patients with Heart Failure.心脏康复对心力衰竭患者预后的影响:呼吸肌力量的变化
J Clin Med. 2020 Mar 30;9(4):952. doi: 10.3390/jcm9040952.
2
Respiratory muscle weakness increases dead-space ventilation ratio aggravating ventilation-perfusion mismatch during exercise in patients with chronic heart failure.在慢性心力衰竭患者运动期间,呼吸肌无力增加死腔通气比,加重通气/血流不匹配。
Respirology. 2019 Feb;24(2):154-161. doi: 10.1111/resp.13432. Epub 2018 Nov 14.
3
Inspiratory work capacity is more severely depressed than inspiratory muscle strength in patients with heart failure: Novel applications for inspiratory muscle training.在心力衰竭患者中,吸气工作能力比吸气肌力量下降得更严重:吸气肌训练的新应用。
Int J Cardiol. 2016 Oct 15;221:622-6. doi: 10.1016/j.ijcard.2016.07.102. Epub 2016 Jul 8.
4
Inspiratory muscle strength and six-minute walking distance in heart failure: Prognostic utility in a 10 years follow up cohort study.在心力衰竭中吸气肌力量和 6 分钟步行距离:10 年随访队列研究中的预后价值。
PLoS One. 2019 Aug 1;14(8):e0220638. doi: 10.1371/journal.pone.0220638. eCollection 2019.
5
Muscle impairment in neuromuscular disease using an expiratory/inspiratory pressure ratio.使用呼气/吸气压力比值评估神经肌肉疾病中的肌肉损伤
Respir Care. 2015 Apr;60(4):533-9. doi: 10.4187/respcare.03367. Epub 2015 Jan 13.
6
Is serial determination of inspiratory muscle strength a useful prognostic marker in chronic heart failure?连续测定吸气肌力量在慢性心力衰竭中是否是一个有用的预后标志物?
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):156-61. doi: 10.1097/HJR.0b013e3282f0d6ea.
7
Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment.慢性心力衰竭患者呼吸肌力量的有效性、预后价值及最佳截断值随β受体阻滞剂治疗而变化。
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):424-9. doi: 10.1097/HJR.0b013e3283030a7e.
8
Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction.射血分数保留的心力衰竭患者呼吸肌无力的患病率和预后。
Respir Med. 2020 Jan;161:105834. doi: 10.1016/j.rmed.2019.105834. Epub 2019 Nov 20.
9
Maximal sniff mouth pressure compared with maximal inspiratory pressure in acute respiratory failure.急性呼吸衰竭时最大吸气鼻压与最大吸气压力的比较
Chest. 1991 Jul;100(1):175-8. doi: 10.1378/chest.100.1.175.
10
Correlation between respiratory muscle weakness and frailty status as risk markers for poor outcomes in patients with cardiovascular disease.呼吸肌无力与虚弱状态的相关性,作为心血管疾病患者不良预后的风险标志物。
Eur J Cardiovasc Nurs. 2022 Nov 23;21(8):782-790. doi: 10.1093/eurjcn/zvac014.

引用本文的文献

1
Reference values for respiratory muscle strength and maximal voluntary ventilation in the Brazilian adult population: A multicentric study.巴西成年人呼吸肌力量和最大自主通气量的参考值:一项多中心研究。
PLoS One. 2024 Nov 21;19(11):e0313209. doi: 10.1371/journal.pone.0313209. eCollection 2024.
2
Artificial Intelligence (AI)-Driven Frailty Prediction Using Electronic Health Records in Hospitalized Patients With Cardiovascular Disease.利用电子健康记录通过人工智能驱动对心血管疾病住院患者进行衰弱预测
Circ Rep. 2024 Oct 29;6(11):495-504. doi: 10.1253/circrep.CR-24-0112. eCollection 2024 Nov 8.
3
Improving Respiratory Muscle Strength and Overall Function in Patients With Cardiovascular Disease Through Rehabilitation Hospitals.

本文引用的文献

1
Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction.射血分数保留的心力衰竭患者呼吸肌无力的患病率和预后。
Respir Med. 2020 Jan;161:105834. doi: 10.1016/j.rmed.2019.105834. Epub 2019 Nov 20.
2
Standard Cardiac Rehabilitation Program for Heart Failure.心力衰竭的标准心脏康复计划。
Circ J. 2019 Nov 25;83(12):2394-2398. doi: 10.1253/circj.CJ-19-0670. Epub 2019 Nov 9.
3
More Impaired Dynamic Ventilatory Muscle Oxygenation in Congestive Heart Failure than in Chronic Obstructive Pulmonary Disease.
通过康复医院改善心血管疾病患者的呼吸肌力量和整体功能。
Cardiol Res. 2024 Feb;15(1):56-66. doi: 10.14740/cr1616. Epub 2024 Feb 28.
4
The effect of cardiac rehabilitation on cardiopulmonary function after coronary artery bypass grafting: A systematic review and meta-analysis.心脏康复对冠状动脉旁路移植术后心肺功能的影响:一项系统评价和荟萃分析。
iScience. 2023 Sep 9;26(12):107861. doi: 10.1016/j.isci.2023.107861. eCollection 2023 Dec 15.
5
Skeletal muscle Nox4 knockout prevents and Nox2 knockout blunts loss of maximal diaphragm force in mice with heart failure with reduced ejection fraction.骨骼肌 Nox4 敲除可预防,而 Nox2 敲除可减轻射血分数降低的心力衰竭小鼠最大膈肌无力的丧失。
Free Radic Biol Med. 2023 Jan;194:23-32. doi: 10.1016/j.freeradbiomed.2022.11.025. Epub 2022 Nov 24.
6
Lung Function and Inspiratory Muscle Strength in Heart Failure: Can They be Considered Potential Prognostic Markers?心力衰竭患者的肺功能和吸气肌力量:它们能否被视为潜在的预后标志物?
Arq Bras Cardiol. 2022 Apr;118(4):692-693. doi: 10.36660/abc.20211060.
7
Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation.心血管疾病中的吸气肌功能障碍:对心脏康复的影响。
Prog Cardiovasc Dis. 2022 Jan-Feb;70:49-57. doi: 10.1016/j.pcad.2021.10.002. Epub 2021 Oct 22.
与慢性阻塞性肺疾病相比,充血性心力衰竭患者动态通气肌氧合受损更严重。
J Clin Med. 2019 Oct 7;8(10):1641. doi: 10.3390/jcm8101641.
4
Change in renal function associated with drug treatment in heart failure: national guidance.肾功能变化与心力衰竭药物治疗相关:国家指南。
Heart. 2019 Jun;105(12):904-910. doi: 10.1136/heartjnl-2018-314158.
5
Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review.心力衰竭患者运动不耐受:JACC 最新综述。
J Am Coll Cardiol. 2019 May 7;73(17):2209-2225. doi: 10.1016/j.jacc.2019.01.072.
6
Respiratory muscle weakness increases dead-space ventilation ratio aggravating ventilation-perfusion mismatch during exercise in patients with chronic heart failure.在慢性心力衰竭患者运动期间,呼吸肌无力增加死腔通气比,加重通气/血流不匹配。
Respirology. 2019 Feb;24(2):154-161. doi: 10.1111/resp.13432. Epub 2018 Nov 14.
7
Inspiratory Muscle Training Improves Intercostal and Forearm Muscle Oxygenation in Patients With Chronic Heart Failure: Evidence of the Origin of the Respiratory Metaboreflex.吸气肌训练改善慢性心力衰竭患者的肋间肌和前臂肌肉氧合:呼吸代谢反射起源的证据。
J Card Fail. 2017 Sep;23(9):672-679. doi: 10.1016/j.cardfail.2017.05.003. Epub 2017 May 9.
8
Performance of AHEAD Score in an Asian Cohort of Acute Heart Failure With Either Preserved or Reduced Left Ventricular Systolic Function.AHEAD评分在亚洲左心室收缩功能保留或降低的急性心力衰竭队列中的表现。
J Am Heart Assoc. 2017 May 4;6(5):e004297. doi: 10.1161/JAHA.116.004297.
9
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南:欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组(由10个学会的代表和特邀专家组成)由欧洲心血管预防与康复协会(EACPR)特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
10
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.